Communiqués Lotus Pharmaceuticals, Inc.

Actions

LTUS

US5457152032

Produits pharmaceutiques

Marché Fermé - OTC Markets 15:30:01 24/09/2026			Varia. 5j.	Varia. 1 janv.
0,004390 ^USD	-10,41%		+8,64%	+46,67%

31/07/23

Amarin et Lotus Pharmaceuticals concluent un accord de distribution exclusive du Vazkepa dans 10 pays asiatiques

Communiqués

30/12	Lotus Pharmaceutical Supports Street Medicine Program to Expand Access to Care for Those Most in Need	AQ
12/08/25	Lotus Pharmaceutical Achieves New First-Half Record in Revenue for 2025, While Q2 Impacted by FX and Timing of Lenalidomide Sales	AQ
21/02/25	Lotus announces FDA acceptance of Potential First-to-File ANDA Submission for Voclosporin soft gelatin capsules, a generic equivalent to Lupkynis	AQ
08/11/24	Lotus Achieves Second-Highest Quarterly Performance in Company History with 3Q24 Financial Results	AQ
08/07/24	Lotus Pharmaceuticals Secures Three HR Asia Awards for 2024	AQ
07/06/24	Lotus Pharmaceuticals announces the acquisition of Teva Pharma Thailand, expanding its footprint in Southeast Asia	AQ
10/11/23	Lotus Achieves Historic Q3 2023 Results with YTD EPS Soaring to a Record NTD 14.19 Marking a 29% Year-on-Year Growth	AQ
12/09/23	Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year	AQ
14/08/23	Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year	AQ
27/03/23	Lotus Announces MFDS Approval for GRALISE SR, Once-Daily Tablets for Post-Herpetic Neuralgia	AQ
13/03/23	Lotus revenues grow by 16% and profit doubles year over year	AQ
14/12/22	Lotus acquires Alimta in Taiwan from Lilly	AQ
12/07/22	Lotus Pharmaceuticals - Aztiq and Innobic officially become Lotus's majority shareholders	AQ
16/05/22	Lotus Reports Solid Performance in First Quarter of 2022	AQ
30/03/22	Lotus Pharmaceuticals : Unaudited Financial Statement	PU
23/03/22	Lotus Pharmaceuticals acquires Cialis (Tadalafil) in Taiwan from Lilly	AQ
17/03/22	Lotus achieves another record high EPS for FY2021	AQ
29/11/21	A powerful investment alliance of Aztiq and Innobic acquires Alvogen's shares in Lotus and Adalvo in a US$475m deal	AQ
22/11/21	Lotus Pharmaceuticals : Informational Disclosure	PU
22/11/21	Lotus Pharmaceuticals : Unaudited Financial Statements	PU
19/04/21	Lotus Pharmaceuticals : PTT invests in Lotus	AQ
26/02/20	LOTUS PHARMACEUTICALS, INC. : Other Events (form 8-K)	AQ